WallStreetZenWallStreetZen

NASDAQ: IART
Integra Lifesciences Holdings Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Integra Lifesciences Holdings earnings were $23.6M for the trailing 12 months ending Jun 30, 2024, with -81.1% growth year over year. The latest IART earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$12.4M, up 278% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IART reported annual earnings of $67.7M, with -62.5% growth. The next IART earnings date is Oct 23, 2024.

IART past earnings growth

How has IART's earnings growth performed historically?
Company
-81.13%
Industry
45.13%
Market
57.37%
IART's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IART's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IART's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IART earnings history

Current Revenue
$1.6B
Current Earnings
$23.6M
Current Profit Margin
1.5%

IART Return on Equity

Current Company
1.5%
Current Industry
9.3%
Current Market
33.7%
IART's Return on Equity (1.5%)... subscribe to Premium to read more.
High Return on Equity Performance

IART Return on Assets

Current Company
0.6%
Current Industry
5.5%
IART is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IART announces earnings.

IART Return on Capital Employed

Current Company
2.3%
Current Industry
8.9%
IART's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IART vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IART$216.16M$23.65M-24.09%$0.30
INMD$165.20M$149.20M+22.51%$1.78
AHCO-$184.52M-$691.28MN/A-$5.17
NVCR-$203.08M-$192.74MN/A-$1.80
IRTC-$98.07M-$131.59MN/A-$4.27
View Top Medical Device Stocks

IART earnings dates

Next earnings date
Oct 23, 2024

Integra Lifesciences Holdings Earnings Reports & History FAQ

What were Integra Lifesciences Holdings's earnings last quarter?

On IART's earnings call on Invalid Date, Integra Lifesciences Holdings (NASDAQ: IART) reported Q2 2024 earnings per share (EPS) of -$0.16, up 420% year over year. Total IART earnings for the quarter were -$12.40 million. In the same quarter last year, Integra Lifesciences Holdings's earnings per share (EPS) was $0.05.

If you're new to stock investing, here's how to buy Integra Lifesciences Holdings stock.

When does Integra Lifesciences Holdings report earnings?

The next IART earnings call is Invalid Date. Add IART to your watchlist to be reminded of Integra Lifesciences Holdings's next earnings date.

Is Integra Lifesciences Holdings profitable or losing money?

As of the last Integra Lifesciences Holdings earnings report, Integra Lifesciences Holdings is currently profitable. Integra Lifesciences Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2024 was $23.65 million, a 81.99% decrease year over year.

What was IART's earnings growth in the past year?

As of Integra Lifesciences Holdings's earnings date in Invalid Date, Integra Lifesciences Holdings's earnings has grown -81.13% year over year. This is 126.27 percentage points lower than the US Medical Devices industry earnings growth rate of 45.13%. IART earnings in the past year totalled $23.65 million.

What are Integra Lifesciences Holdings's earnings expectations?

The current EPS estimate for Integra Lifesciences Holdings's earnings report in Invalid Date is $0.39.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.